Let's Combinate - Drugs + Devices

174 - How GLP-1s Like Ozempic & Wegovy Are Changing Pharma with Ben Locwin


Listen Later

๐Ÿš€ Stay ahead in combination products, pharma, and medical devices ๐Ÿ‘‰ https://www.letscombinate.com๐ŸŽ™๏ธ

Listen to more expert discussions on regulations, drug delivery, and quality ๐Ÿ‘‰ https://www.letscombinate.com/

Get expert insights on FDA regulations, risk management, quality systems, and the latest trends in drug-device combination products.

Ben Locwin discusses the science, quality, and future of GLP-1 receptor agonists, revolutionary drugs used in diabetes and obesity treatment. The episode explores the history and development of GLP-1s, their commercial viability, manufacturing challenges, and regulatory landscapes. Ben dives into the mechanisms of GLP-1s, including their influence on appetite, blood sugar, and gastrointestinal effects. They also touch on the capacity issues in production, the impact of compounding, and the sustainability concerns associated with injector pens. The conversation provides an in-depth look at the pharmaceutical industryโ€™s response to the surge in GLP-1 demand, highlighting the broader implications for patient care and market trends.00:00 Introduction to GLP Receptor Agonists00:46 Guest Introduction: Ben Locwin01:48 Historical Context of GLP-1 Development05:54 Mechanisms and Effects of GLP-109:51 Market Impact and Manufacturing Challenges11:16 Regulatory and Advertising Considerations17:44 Sustainability and Injector Pen Issues19:40 Risk Management and Future Directions23:31 ConclusionBen Locwin is a Healthcare Executive, MMA fighter, Jiu Jtisu pro and Quality and Regulatory SME working in medical devices, pharma and other regulated industries.Subhi Saadeh is a Quality Professional and host of Let's Combinate. With a background in Quality, Manufacturing Operations and R&D he's worked in Large Medical Device/Pharma organizations to support the development and launch of Hardware Devices, Disposable Devices, and Combination Products for Vaccines, Generics, and Biologics. Subhi serves currently as the International Committee Chair for the Combination Products Coalition(CPC) and as a member of ASTM Committee E55 and also served as a committee member on AAMI's Combination Products Committee.For questions, inquiries or suggestions please reach out at letscombinate.com or on the show's LinkedIn Page.

...more
View all episodesView all episodes
Download on the App Store

Let's Combinate - Drugs + DevicesBy Subhi Saadeh

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

13 ratings


More shows like Let's Combinate - Drugs + Devices

View all
Marketplace by Marketplace

Marketplace

8,622 Listeners

Fresh Air by NPR

Fresh Air

37,766 Listeners

Planet Money by NPR

Planet Money

30,734 Listeners

Global Medical Device Podcast powered by Greenlight Guru by Greenlight Guru + Medical Device Entrepreneurs

Global Medical Device Podcast powered by Greenlight Guru

91 Listeners

The Daily by The New York Times

The Daily

110,865 Listeners

Up First from NPR by NPR

Up First from NPR

56,021 Listeners

The Indicator from Planet Money by NPR

The Indicator from Planet Money

9,501 Listeners

SmartLess by Jason Bateman, Sean Hayes, Will Arnett

SmartLess

57,297 Listeners

The Ezra Klein Show by New York Times Opinion

The Ezra Klein Show

15,371 Listeners